• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

革兰氏阴性菌通过自转运蛋白介导展示补体受体配体可增强抗体反应并减轻疾病严重程度。

Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity.

作者信息

Holland-Tummillo Kristen M, Shoudy Lauren E, Steiner Donald, Kumar Sudeep, Rosa Sarah J, Namjoshi Prachi, Singh Anju, Sellati Timothy J, Gosselin Edmund J, Hazlett Karsten Ro

机构信息

Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.

Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA.

出版信息

Pathogens. 2020 May 14;9(5):375. doi: 10.3390/pathogens9050375.

DOI:10.3390/pathogens9050375
PMID:32422907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7281241/
Abstract

The targeting of immunogens/vaccines to specific immune cells is a promising approach for amplifying immune responses in the absence of exogenous adjuvants. However, the targeting approaches reported thus far require novel, labor-intensive reagents for each vaccine and have primarily been shown as proof-of-concept with isolated proteins and/or inactivated bacteria. We have engineered a plasmid-based, complement receptor-targeting platform that is readily applicable to live forms of multiple gram-negative bacteria, including, but not limited to, , , and . Using as a model, we find that targeted bacteria show increased binding and uptake by macrophages, which coincides with increased p38 and p65 phosphorylation. Mice vaccinated with targeted bacteria produce higher titers of specific antibody that recognizes a greater diversity of bacterial antigens. Following challenge with homologous or heterologous isolates, these mice exhibited less weight loss and/or accelerated weight recovery as compared to counterparts vaccinated with non-targeted immunogens. Collectively, these findings provide proof-of-concept for plasmid-based, complement receptor-targeting of live gram-negative bacteria.

摘要

在不使用外源性佐剂的情况下,将免疫原/疫苗靶向特定免疫细胞是增强免疫反应的一种有前景的方法。然而,迄今为止报道的靶向方法针对每种疫苗都需要新型的、耗费人力的试剂,并且主要仅在分离的蛋白质和/或灭活细菌中作为概念验证得到展示。我们构建了一种基于质粒的、靶向补体受体的平台,该平台可轻松应用于多种革兰氏阴性菌的活菌体,包括但不限于 、 、 和 。以 作为模型,我们发现靶向细菌显示出被巨噬细胞的结合和摄取增加,这与p38和p65磷酸化增加相吻合。用靶向细菌接种的小鼠产生更高滴度的特异性抗体,该抗体能识别更多种类的细菌抗原。在用同源或异源分离株攻击后,与接种非靶向免疫原的对应小鼠相比,这些小鼠体重减轻更少和/或体重恢复加快。总体而言,这些发现为基于质粒的、对革兰氏阴性菌活菌体进行补体受体靶向提供了概念验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/99babbc56583/pathogens-09-00375-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/5923858040aa/pathogens-09-00375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/a50a8221efbf/pathogens-09-00375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/f34960cc553c/pathogens-09-00375-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/2db667fa09db/pathogens-09-00375-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/d25644e57367/pathogens-09-00375-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/99babbc56583/pathogens-09-00375-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/5923858040aa/pathogens-09-00375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/a50a8221efbf/pathogens-09-00375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/f34960cc553c/pathogens-09-00375-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/2db667fa09db/pathogens-09-00375-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/d25644e57367/pathogens-09-00375-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510f/7281241/99babbc56583/pathogens-09-00375-g006.jpg

相似文献

1
Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity.革兰氏阴性菌通过自转运蛋白介导展示补体受体配体可增强抗体反应并减轻疾病严重程度。
Pathogens. 2020 May 14;9(5):375. doi: 10.3390/pathogens9050375.
2
Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.灭活的土拉热弗朗西斯菌活疫苗株通过鼻内接种以免疫球蛋白A依赖的方式预防呼吸道土拉菌病。
Infect Immun. 2007 May;75(5):2152-62. doi: 10.1128/IAI.01606-06. Epub 2007 Feb 12.
3
Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).从脾脏、肝脏和肺部白细胞功能的体外分析中得出的模型可预测对土拉弗朗西斯菌活疫苗株(LVS)的疫苗效力。
mBio. 2014 Apr 8;5(2):e00936. doi: 10.1128/mBio.00936-13.
4
Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent subsp. .减毒活土拉弗朗西丝菌疫苗对呼吸道感染强毒. 亚种的保护作用。
Front Cell Infect Microbiol. 2018 May 15;8:154. doi: 10.3389/fcimb.2018.00154. eCollection 2018.
5
Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.目的 2 和 Nlrp3 对于对抗弗朗西斯氏菌活疫苗株的疫苗诱导免疫是可有可无的。
Infect Immun. 2021 Jun 16;89(7):e0013421. doi: 10.1128/IAI.00134-21.
6
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.鉴定土拉弗朗西斯菌外膜蛋白 A(FopA)作为土拉菌病的保护性抗原。
Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.
7
Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.利用基于烟草花叶病毒(TMV)的递送系统开发抗兔热病的多价亚单位疫苗。
PLoS One. 2015 Jun 22;10(6):e0130858. doi: 10.1371/journal.pone.0130858. eCollection 2015.
8
Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection.将固定的细菌免疫原靶向Fc受体可在感染早期逆转革兰氏阴性菌土拉弗朗西斯菌的抗炎特性。
PLoS One. 2015 Jun 26;10(6):e0129981. doi: 10.1371/journal.pone.0129981. eCollection 2015.
9
Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.穿孔素和颗粒酶介导的细胞毒性效应功能对于用定义明确的弗氏土拉弗朗西斯菌亚种 novicida ΔfopC 疫苗株接种后预防土拉弗朗西斯菌至关重要。
Infect Immun. 2012 Jun;80(6):2177-85. doi: 10.1128/IAI.00036-12. Epub 2012 Apr 9.
10
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.一种用于预防由土拉热弗朗西斯菌SchuS4菌株引起的呼吸道兔热病的改良疫苗。
Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8.

引用本文的文献

1
Current vaccine strategies and novel approaches to combatting Francisella infection.当前疫苗策略和新型方法对抗弗朗西斯菌感染。
Vaccine. 2024 Apr 2;42(9):2171-2180. doi: 10.1016/j.vaccine.2024.02.086. Epub 2024 Mar 8.
2
The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection.对弗朗西斯菌的O抗原抗体反应在啮齿动物和高等动物中有所不同,可作为保护作用的一个相关指标。
Pathogens. 2021 Dec 20;10(12):1646. doi: 10.3390/pathogens10121646.
3
and Antibodies.以及抗体。

本文引用的文献

1
Mucosal vaccines: Strategies and challenges.黏膜疫苗:策略与挑战。
Immunol Lett. 2020 Jan;217:116-125. doi: 10.1016/j.imlet.2019.10.013. Epub 2019 Oct 25.
2
Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.先前存在的黄热病免疫力会损害并调节对蜱传脑炎疫苗接种的抗体反应。
NPJ Vaccines. 2019 Sep 6;4:38. doi: 10.1038/s41541-019-0133-5. eCollection 2019.
3
Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses.靶向传统树突状细胞以微调抗体反应。
Microorganisms. 2021 Oct 12;9(10):2136. doi: 10.3390/microorganisms9102136.
4
Co-Opting Host Receptors for Targeted Delivery of Bioconjugates-From Drugs to Bugs.共受体介导的生物缀合物靶向递送-从药物到细菌。
Molecules. 2021 Mar 9;26(5):1479. doi: 10.3390/molecules26051479.
Front Immunol. 2019 Jul 4;10:1529. doi: 10.3389/fimmu.2019.01529. eCollection 2019.
4
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment.开发针对HER3的有效癌症治疗疗法。
Biol Proced Online. 2019 Mar 19;21:5. doi: 10.1186/s12575-019-0093-1. eCollection 2019.
5
Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site.树突状细胞靶向 Ccl3- 和 Xcl1 融合 DNA 疫苗在诱导免疫应答和最佳递送部位方面存在差异。
Sci Rep. 2019 Feb 12;9(1):1820. doi: 10.1038/s41598-018-38080-7.
6
From Squirrels to Biological Weapons: The Early History of Tularemia.从松鼠到生物武器:兔热病的早期历史。
Am J Med Sci. 2018 Oct;356(4):319-328. doi: 10.1016/j.amjms.2018.06.006. Epub 2018 Jun 15.
7
A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.一种新型蛋白质组微阵列可区分口服疫苗接种和实验性挑战后人体抗体反应的靶标。
mSphere. 2018 Aug 1;3(4):e00260-18. doi: 10.1128/mSphere.00260-18.
8
Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review.主动靶向纳米粒给药系统在化疗药物及中药/天然药物治疗癌症中的应用:系统评价。
Int J Nanomedicine. 2018 Jul 4;13:3921-3935. doi: 10.2147/IJN.S165210. eCollection 2018.
9
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.佐剂的相关性:已上市疫苗中的佐剂概述。
Semin Immunol. 2018 Oct;39:14-21. doi: 10.1016/j.smim.2018.05.001. Epub 2018 May 23.
10
Complement C3 Drives Autophagy-Dependent Restriction of Cyto-invasive Bacteria.补体 C3 驱动自噬依赖性的细胞侵袭性细菌限制。
Cell Host Microbe. 2018 May 9;23(5):644-652.e5. doi: 10.1016/j.chom.2018.04.008.